首页 › 滤泡性淋巴瘤 › 加利福尼亚州 › Baldwin Park
Baldwin Park CA 滤泡性淋巴瘤临床试验
16项针对 滤泡性淋巴瘤的研究正在 Baldwin Park及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
招募中3 期
- City of Hope Comprehensive Cancer Center, Duarte · 距离 4 英里
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
招募中2/3 期
- City of Hope - Duarte Cancer Center ( Site 1301), Duarte · 距离 4 英里
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
招募中1 期
- City of Hope, Duarte · 距离 4 英里
Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients With Relapsed or Refractory Grade 1-3a Follicular Lymphoma
招募中2 期
- City of Hope Medical Center, Duarte · 距离 4 英里
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
招募中1 期
- City of Hope, Duarte · 距离 4 英里
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
招募中2 期
- Research Site, Duarte · 距离 4 英里
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
招募中1 期
- City of Hope Comprehensive Cancer Center, Duarte · 距离 4 英里
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
招募中1/2 期
- City of Hope, Duarte · 距离 4 英里
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
招募中1 期
- City of Hope, Duarte · 距离 4 英里
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
招募中1 期
- City of Hope, Duarte · 距离 4 英里
Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma
招募中1 期
- City of Hope Medical Center, Duarte · 距离 4 英里
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
招募中3 期
- City of Hope Comprehensive Cancer Center, Duarte · 距离 4 英里
Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
招募中1 期
- City of Hope Medical Center, Duarte · 距离 4 英里
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
招募中1/2 期
- City of Hope, Duarte · 距离 4 英里
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
招募中1 期
- City of Hope, Duarte · 距离 4 英里
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Duarte · 距离 4 英里
其他城市的 滤泡性淋巴瘤试验
- New York City, NY24 项研究
- Milwaukee, WI19 项研究
- Nashville, TN18 项研究
- Houston, TX18 项研究
- Boston, MA17 项研究
- Seattle, WA15 项研究
- Durham, NC15 项研究
- Columbus, OH13 项研究
- Salt Lake City, UT13 项研究
- Chicago, IL12 项研究
- San Antonio, TX12 项研究
- Philadelphia, PA12 项研究
Baldwin Park的其他研究
- 乳腺癌44 项研究
- 急性髓系白血病40 项研究
- 结直肠癌37 项研究
- 非小细胞肺癌36 项研究
- 癌症（所有类型）34 项研究
- 前列腺癌30 项研究
- 转移性癌症30 项研究
- 骨髓增生异常综合征26 项研究
- 卵巢癌25 项研究
- 肺癌24 项研究
- 多发性骨髓瘤23 项研究
- 胃癌22 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。